Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Arthritis Care & Research
|
April 14, 2019
Systematic Review and Appraisal of the Cross-Cultural Validity of Functional Status Assessment Measures in Rheumatoid Arthritis
Stephanie C Kulhawy-Wibe, JoAnn Zell, Kaleb Michaud, et al.
Annals of the Rheumatic Diseases
|
June 17, 2016
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
Laura C Cappelli, Anna Kristina Gutierrez, Alan N Baer, et al.
Journal of Endocrinological Investigation
|
July 14, 2023
Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study
C Ceolin, A Scala, M Dall'Agnol, et al.
RMD Open
|
November 1, 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
Paola Ghanem, Joseph C Murray, Kristen A Marrone, et al.
Journal for Immunotherapy of Cancer
|
March 31, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, et al.
ACR Open Rheumatology
|
February 11, 2021
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry
Joel M Kremer, Clifton O Bingham, Laura C Cappelli, et al.
Rheumatology Advances in Practice
|
June 7, 2022
Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey
Eugenia Yupei Chock, Michael Putman, Richard Conway, et al.
The Oncologist
|
June 4, 2017
Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
Jarushka Naidoo, Laura C Cappelli, Patrick M Forde, et al.
Annals of the Rheumatic Diseases
|
April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
Deanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study
Alice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Arthritis Care & Research
|
April 14, 2019
Systematic Review and Appraisal of the Cross-Cultural Validity of Functional Status Assessment Measures in Rheumatoid Arthritis
Stephanie C Kulhawy-Wibe, JoAnn Zell, Kaleb Michaud, et al.
Annals of the Rheumatic Diseases
|
June 17, 2016
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
Laura C Cappelli, Anna Kristina Gutierrez, Alan N Baer, et al.
Journal of Endocrinological Investigation
|
July 14, 2023
Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study
C Ceolin, A Scala, M Dall'Agnol, et al.
RMD Open
|
November 1, 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
Paola Ghanem, Joseph C Murray, Kristen A Marrone, et al.
Journal for Immunotherapy of Cancer
|
March 31, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, et al.
ACR Open Rheumatology
|
February 11, 2021
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry
Joel M Kremer, Clifton O Bingham, Laura C Cappelli, et al.
Rheumatology Advances in Practice
|
June 7, 2022
Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey
Eugenia Yupei Chock, Michael Putman, Richard Conway, et al.
The Oncologist
|
June 4, 2017
Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
Jarushka Naidoo, Laura C Cappelli, Patrick M Forde, et al.
Annals of the Rheumatic Diseases
|
April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
Deanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study
Alice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
Page
of 17